Apellis Pharmaceuticals to Hold Fourth Quarter and Full Year 2020 Earnings Conference Call on February 25, 2021
February 18 2021 - 4:05PM
Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global
biopharmaceutical company and leader in targeted C3 therapies,
today announced that the company will host a conference call and
webcast to discuss its fourth quarter and full year 2020 financial
results on Thursday, February 25, 2021 at 4:30 p.m. ET.
The event will be available live by dialing (866) 774-0323
(Domestic) or (602) 563-8683 (International) and entering the
conference ID # 6956712 or via webcast from the “Events and
Presentations” page of the “Investors and Media” section of the
company’s website
at https://investors.apellis.com/events-and-presentations. A
replay of the webcast will be available for 90 days following the
event.
About ApellisApellis Pharmaceuticals, Inc. is a
global biopharmaceutical company that is committed to leveraging
courageous science, creativity, and compassion to deliver
life-changing therapies. Leaders in targeted C3 therapies, we aim
to develop transformative therapies for a broad range of
debilitating diseases that are driven by excessive activation of
the complement cascade, including those within hematology,
ophthalmology, nephrology, and neurology. For more information,
please visit www.apellis.com.
Investor Contact:Argot
Partnersapellis@argotpartners.com +1 212.600.1902
Apellis Pharmaceuticals (NASDAQ:APLS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Apellis Pharmaceuticals (NASDAQ:APLS)
Historical Stock Chart
From Apr 2023 to Apr 2024